BIO
Price
$305.04
Change
+$3.34 (+1.11%)
Updated
Jul 22, 12:39 PM (EDT)
Capitalization
8.11B
8 days until earnings call
Intraday BUY SELL Signals
MTD
Price
$1298.17
Change
+$24.40 (+1.92%)
Updated
Jul 21 closing price
Capitalization
26.23B
8 days until earnings call
Intraday BUY SELL Signals
TMO
Price
$523.46
Change
-$2.77 (-0.53%)
Updated
Jul 21 closing price
Capitalization
194.53B
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BIO or MTD or TMO

BIO vs MTD vs TMO Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2026
Stock price -- (BIO: $301.70MTD: $1298.17TMO: $523.46)
Brand notoriety: BIO, MTD and TMO are all not notable
MTD and TMO are part of the Medical Specialties industry, and BIO is in the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BIO: 79%, MTD: 81%, TMO: 152%
Market capitalization -- BIO: $8.11B, MTD: $26.23B, TMO: $194.53B
$MTD [@Medical Specialties] is valued at $26.23B. $TMO’s [@Medical Specialties] market capitalization is $ $194.53B. $BIO [@Medical/Nursing Services] has a market capitalization of $ $8.11B. The market cap for tickers in the [@Medical Specialties] industry ranges from $ $3.82T to $ $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $ $173.61B to $ $0. The average market capitalization across the [@Medical Specialties] industry is $ $16.68B. The average market capitalization across the [@Medical/Nursing Services] industry is $ $5.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 1 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s), and TMO’s FA Score reflects 2 green FA rating(s).

  • BIO’s FA Score: 1 green, 4 red.
  • MTD’s FA Score: 1 green, 4 red.
  • TMO’s FA Score: 2 green, 3 red.
According to our system of comparison, TMO is a better buy in the long-term than MTD, which in turn is a better option than BIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 5 TA indicator(s) are bullish while MTD’s TA Score has 5 bullish TA indicator(s), and TMO’s TA Score reflects 5 bullish TA indicator(s).

  • BIO’s TA Score: 5 bullish, 3 bearish.
  • MTD’s TA Score: 5 bullish, 5 bearish.
  • TMO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BIO is a better buy in the short-term than MTD, which in turn is a better option than TMO.

Price Growth

BIO (@Medical/Nursing Services) experienced а +1.13% price change this week, while MTD (@Medical Specialties) price change was -1.27% , and TMO (@Medical Specialties) price fluctuated -1.99% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.61%. For the same industry, the average monthly price growth was -3.67%, and the average quarterly price growth was -20.44%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.48%. For the same industry, the average monthly price growth was +8.99%, and the average quarterly price growth was +0.10%.

Reported Earning Dates

BIO is expected to report earnings on Jul 30, 2026.

MTD is expected to report earnings on Jul 30, 2026.

TMO is expected to report earnings on Jul 23, 2026.

Industries' Descriptions

@Medical/Nursing Services (-4.61% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (+0.48% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($195B) has a higher market cap than MTD($26.2B) and BIO($8.11B). BIO has higher P/E ratio than MTD and TMO: BIO (50.20) vs MTD (30.49) and TMO (28.78). BIO YTD gains are higher at: -0.426 vs. MTD (-6.887) and TMO (-9.483). TMO has higher annual earnings (EBITDA): 11.7B vs. MTD (1.25B) and BIO (440M). BIO has more cash in the bank: 1.57B vs. TMO (1.12B) and MTD (60.6M). BIO has less debt than MTD and TMO: BIO (1.38B) vs MTD (2.23B) and TMO (43.2B). TMO has higher revenues than MTD and BIO: TMO (45.2B) vs MTD (4.09B) and BIO (2.59B).
BIOMTDTMO
Capitalization8.11B26.2B195B
EBITDA440M1.25B11.7B
Gain YTD-0.426-6.887-9.483
P/E Ratio50.2030.4928.78
Revenue2.59B4.09B45.2B
Total Cash1.57B60.6M1.12B
Total Debt1.38B2.23B43.2B
FUNDAMENTALS RATINGS
BIO vs MTD vs TMO: Fundamental Ratings
BIO
MTD
TMO
OUTLOOK RATING
1..100
574131
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
99
Overvalued
13
Undervalued
PROFIT vs RISK RATING
1..100
10010090
SMR RATING
1..100
90262
PRICE GROWTH RATING
1..100
495148
P/E GROWTH RATING
1..100
104331
SEASONALITY SCORE
1..100
855085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TMO's Valuation (13) in the Medical Specialties industry is significantly better than the same rating for BIO (85) and is significantly better than the same rating for MTD (99). This means that TMO's stock grew significantly faster than BIO’s and significantly faster than MTD’s over the last 12 months.

TMO's Profit vs Risk Rating (90) in the Medical Specialties industry is in the same range as BIO (100) and is in the same range as MTD (100). This means that TMO's stock grew similarly to BIO’s and similarly to MTD’s over the last 12 months.

MTD's SMR Rating (2) in the Medical Specialties industry is somewhat better than the same rating for TMO (62) and is significantly better than the same rating for BIO (90). This means that MTD's stock grew somewhat faster than TMO’s and significantly faster than BIO’s over the last 12 months.

TMO's Price Growth Rating (48) in the Medical Specialties industry is in the same range as BIO (49) and is in the same range as MTD (51). This means that TMO's stock grew similarly to BIO’s and similarly to MTD’s over the last 12 months.

BIO's P/E Growth Rating (10) in the Medical Specialties industry is in the same range as TMO (31) and is somewhat better than the same rating for MTD (43). This means that BIO's stock grew similarly to TMO’s and somewhat faster than MTD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOMTDTMO
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
54%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
57%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
57%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
60%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 6 days ago
66%
Bullish Trend 7 days ago
60%
Bullish Trend 7 days ago
61%
Declines
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 3 days ago
66%
Bearish Trend 1 day ago
63%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
59%
Aroon
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
53%
Bullish Trend 1 day ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
BIO
Daily Signal:
Gain/Loss:
MTD
Daily Signal:
Gain/Loss:
TMO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MIR16.270.50
+3.17%
Mirion Technologies
CCXI14.830.44
+3.06%
Churchill Capital Corp XI
KHC25.79-0.07
-0.27%
Kraft Heinz Company (The)
TRAW0.61N/A
-0.67%
Traws Pharma Inc
NYXH1.54-0.02
-1.28%
Nyxoah SA